You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,750,023


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,750,023
Title:Quinuclidine derivatives and medicinal compositions containing the same
Abstract: The invention provides 3-(2-hydroxy-2,2-dithien-2-ylacetoxy)-1-(3-phenoxypropyl)-1-azoniabicyclo- [2.2.2]octane in salt form, pharmaceutical compositions comprising it, and methods of using it for treatment of respiratory disorders, in association with .beta..sub.2 agonist.
Inventor(s): Fernandez Forner; Maria Dolors (Barcelona, ES), Prat Quinones; Maria (Barcelona, ES), Buil Albero; Maria Antonia (Barcelona, ES)
Assignee: Almirall, S.A. (N/A)
Application Number:12/074,929
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of US Patent 7,750,023: A Detailed Analysis

Introduction

US Patent 7,750,023, titled "Quinuclidine derivatives and medicinal compositions containing the same," is a patent that protects specific chemical compounds and their applications in medicine. To fully comprehend the patent's scope and claims, it is essential to delve into its various components, including the background, summary, detailed description, and the claims themselves.

Background of the Patent

The patent for Quinuclidine derivatives was granted to address the need for new therapeutic agents, particularly in the fields of neurology and psychiatry. Quinuclidine derivatives are known for their potential in treating various neurological and psychiatric disorders due to their interaction with specific receptors in the brain.

Summary of the Invention

The patent summarizes the invention as relating to new quinuclidine derivatives, their preparation, and their use in medicinal compositions. These derivatives are designed to have improved efficacy and reduced side effects compared to existing treatments. The summary highlights the structural features of these compounds and their potential therapeutic applications.

Detailed Description of the Invention

Chemical Structure and Synthesis

The detailed description section provides a thorough explanation of the chemical structure of the quinuclidine derivatives, including their synthesis methods. This section is crucial for understanding how the compounds are prepared and what specific modifications have been made to enhance their therapeutic properties.

Therapeutic Applications

The patent outlines the potential therapeutic applications of these quinuclidine derivatives, including their use in treating conditions such as schizophrenia, depression, and anxiety disorders. It also discusses the pharmacological profiles of these compounds, including their receptor binding affinities and in vivo efficacy.

Claims of the Patent

Independent Claims

The independent claims of the patent define the broad scope of the invention. These claims typically describe the general structure of the quinuclidine derivatives and their use in medicinal compositions. For example:

  • Claim 1: A quinuclidine derivative of a specific structural formula, useful for treating neurological and psychiatric disorders.
  • Claim 2: A method of treating a neurological or psychiatric disorder by administering a quinuclidine derivative.

Dependent Claims

Dependent claims narrow down the scope of the independent claims by adding specific details or limitations. These claims might include:

  • Claim 3: The quinuclidine derivative of Claim 1, wherein the derivative has a particular substituent at a specific position.
  • Claim 4: The method of Claim 2, wherein the quinuclidine derivative is administered in a specific dosage form.

Patent Scope and Breadth

The scope of the patent is determined by the language of the claims. Broader claims can encompass a wider range of compounds and uses, while narrower claims are more specific and limited. The patent scope is crucial for determining what is protected and what is not.

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Patents with shorter, more focused independent claims tend to have a narrower scope, while those with longer, more complex claims may have a broader scope[3].

Patent Landscape

Prior Art and Related Patents

To understand the patent landscape surrounding US Patent 7,750,023, it is necessary to conduct a thorough search of prior art and related patents. This involves searching databases such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and other international patent databases[4].

Competing Patents

Identifying competing patents in the same field helps in understanding the competitive landscape. For instance, other patents related to quinuclidine derivatives or similar therapeutic agents can provide insights into the existing intellectual property landscape.

Practical Applications and Real-World Impact

The practical applications of the quinuclidine derivatives protected by this patent are significant. By specifying the use of these compounds in treating specific neurological and psychiatric disorders, the patent demonstrates a practical application that provides tangible benefits. This aligns with the recent USPTO guidance on AI and software patents, which emphasizes the importance of integrating abstract ideas into practical applications to ensure patent eligibility[1].

Enforcement and Litigation

The enforcement of the patent involves ensuring that others do not infringe on the protected claims. This can involve monitoring for potential infringers and taking legal action if necessary. Litigation may arise if there are disputes over the validity or scope of the patent claims.

Key Takeaways

  • Chemical Structure and Synthesis: The patent provides detailed information on the chemical structure and synthesis of quinuclidine derivatives.
  • Therapeutic Applications: The compounds are designed for treating neurological and psychiatric disorders.
  • Claims: The patent includes both independent and dependent claims that define the scope of the invention.
  • Patent Scope: The scope is determined by the language of the claims, with broader claims encompassing a wider range of compounds and uses.
  • Patent Landscape: Understanding prior art and competing patents is crucial for navigating the intellectual property landscape.

FAQs

What is the main subject matter of US Patent 7,750,023?

The main subject matter of US Patent 7,750,023 is quinuclidine derivatives and their use in medicinal compositions for treating neurological and psychiatric disorders.

How are the quinuclidine derivatives synthesized?

The patent provides a detailed description of the synthesis methods for the quinuclidine derivatives, including the specific chemical reactions and conditions involved.

What are the potential therapeutic applications of the quinuclidine derivatives?

The quinuclidine derivatives are potential therapeutic agents for treating conditions such as schizophrenia, depression, and anxiety disorders.

How is the scope of the patent determined?

The scope of the patent is determined by the language of the claims, with broader claims encompassing a wider range of compounds and uses.

Why is it important to conduct a thorough search of prior art and related patents?

Conducting a thorough search of prior art and related patents helps in understanding the competitive landscape and ensuring that the patent does not infringe on existing intellectual property.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz
  2. 2024 Guidance Update on Patent Subject Matter Eligibility - Federal Register
  3. Patent Claims and Patent Scope - SSRN
  4. Search for Patents - USPTO
  5. US Patent for Quinuclidine derivatives and medicinal compositions containing the same - Justia Patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,750,023

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,750,023

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Spain9901580Jul 14, 1999

International Family Members for US Patent 7,750,023

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1200431 ⤷  Subscribe C300573 Netherlands ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe CA 2013 00002 Denmark ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe PA2013001 Lithuania ⤷  Subscribe
European Patent Office 1200431 ⤷  Subscribe 92132 Luxembourg ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.